Related Experiment Video
Updated: Jun 18, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
The death effector domains of caspase-8 induce terminal differentiation
Ainhoa Mielgo1, Vicente A Torres, Michael C Schmid
1Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California, USA.
Abstract:
The differentiation and senescence programs of metazoans play key roles in regulating normal development and preventing aberrant cell proliferation, such as cancer. These programs are intimately associated with both the mitotic and apoptotic pathways. Caspase-8 is an apical apoptotic initiator that has recently been appreciated to coordinate non-apoptotic roles in the cell. Most of these functions are attributed to the catalytic domain, however, the amino-terminal death effector domains (DED)s, which belong to the death domain superfamily of proteins, can also play key roles during development. Here we describe a novel role for caspase-8 DEDs in regulating cell differentiation and senescence. Caspase-8 DEDs accumulate during terminal differentiation and senescence of epithelial, endothelial and myeloid cells; genetic deletion or shRNA suppression of caspase-8 disrupts cell differentiation, while re-expression of DEDs rescues this phenotype. Among caspase-8 deficient neuroblastoma cells, DED expression attenuated tumor growth in vivo and proliferation in vitro via disruption of mitosis and cytokinesis, resulting in upregulation of p53 and induction of differentiation markers. These events occur independent of caspase-8 catalytic activity, but require a critical lysine (K156) in a microtubule-binding motif in the second DED domain. The results demonstrate a new function for the DEDs of caspase-8, and describe an unexpected mechanism that contributes to cell differentiation and senescence.
Insights
The death effector domains (DEDs) of caspase-8 regulate cell differentiation and senescence. These DEDs, independent of catalytic activity, disrupt mitosis and cytokinesis, impacting tumor growth and promoting cell maturation.
Area of Science:
- Cell Biology
- Developmental Biology
- Cancer Research
Background:
- Cell differentiation and senescence are crucial for development and cancer prevention.
- Caspase-8, a known apoptotic initiator, also has non-apoptotic functions.
- The death effector domains (DEDs) of caspase-8 are implicated in developmental roles.
Purpose of the Study:
- To investigate a novel role for caspase-8 DEDs in regulating cell differentiation and senescence.
- To elucidate the mechanism by which caspase-8 DEDs influence these cellular processes.
Main Methods:
- Analysis of caspase-8 DED accumulation during differentiation and senescence in various cell types.
- Genetic deletion and shRNA suppression of caspase-8 to assess its role in differentiation.
- In vivo and in vitro studies using caspase-8 deficient neuroblastoma cells to evaluate DED function.
- Examination of the catalytic activity independence and the role of a specific lysine residue (K156).
Main Results:
- Caspase-8 DEDs accumulate during terminal differentiation and senescence.
- Loss of caspase-8 impairs cell differentiation, which can be rescued by DED re-expression.
- In neuroblastoma cells, DED expression reduced tumor growth and proliferation by disrupting mitosis and cytokinesis.
- These effects were independent of caspase-8 catalytic activity but dependent on K156 in the DED microtubule-binding motif.
Conclusions:
- Caspase-8 DEDs possess a novel function in regulating cell differentiation and senescence.
- This mechanism contributes to controlling cell proliferation and tumor growth through mitotic and cytokinesis disruption.
- The findings highlight a non-apoptotic role for caspase-8 DEDs in development and cancer prevention.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy

